Targeting immune reconstitution in ADA-SCID: an evolving clinical perspective was a Chiesi-supported industry satellite symposium conducted as part of the scientific program of the ESID EHA SIOPE Symposium in Vienna, Austria in November 2025. This session gathered leading experts on ADA-SCID to discuss the pathophysiology of ADA-SCID, its contemporary treatment, and emerging strategies to improve patient care. Scan the QR code below to view videos and presentations from the symposium, and the main messages presented by the speakers.
The clinical approach to ADA-SCID management Summary of the current treatment options for ADA-SCID, and how availability of these treatments differs across regions. Maria Pia Cicalese, Italy Welcome and introduction Summary of the program, together with learning objectives for the session. Andrew Gennery, United Kingdom Evolving strategies and practical considerations Factors that influence treatment and management decisions when caring for patients with ADA-SCID, and insights into remaining unmet medical needs. Andrew Gennery, United Kingdom The pathophysiology and immunologic mechanisms of ADA-SCID Overview of the pathophysiology of ADA-SCID and how it is diagnosed, including the role of newborn screening. Talal Mousallem, United States of America Chiesi Global Rare Diseases Chiesi Rare Diseases Chiesi Rare Diseases Terms of Use Chiesi Rare Diseases Privacy Policy Email usmedical@chiesi.com